by Combat Cancer | Mar 22, 2025 | News
New Hope for Patients with BCG-Unresponsive NMIBC Combat Medical is proud to announce the commencement of the HIVEC®-HEAT phase 3 trial – the main aim being to evaluate the effectiveness of our hyperthermic intravesical chemotherapy (HIVEC®) treatment with 80mg...
by Combat Cancer | Mar 14, 2025 | News
Colorectal cancer (CRC) is one of the most common malignancies worldwide, with lifestyle and dietary factors playing huge roles in its development. Recent research at Mass General Brigham has highlighted the potential of probiotics, particularly strains like...
by Combat Cancer | Mar 7, 2025 | News
Ovarian Cancer Awareness Month is observed every March in the UK, with its aim being to educate the public, support those affected, and advocate for better research and early detection. Around 7,400 women are diagnosed with ovarian cancer each year in the UK....
by Combat Cancer | Feb 28, 2025 | News
Pancreatic cancer is one of the deadliest forms of cancer, largely because it is difficult to detect in its early stages. Symptoms are often vague, mimicking other conditions, leading to late diagnoses when the disease has already metastasised. This results in poor...
by Combat Cancer | Feb 21, 2025 | News
Pancreatic cancer is one of the most aggressive and fatal cancers worldwide. In Europe, it is the seventh most common cancer but ranks as the third leading cause of cancer-related deaths, surpassing many other forms of cancer in lethality. According to United European...
by Combat Cancer | Feb 14, 2025 | News
Colorectal cancer is the third most common cancer worldwide, but its incidence is changing. While cases in older adults (over 65) are decreasing, early-onset colorectal cancer – cancer affecting individuals under the age of 50 – is on the rise. A new study...
Recent Comments